TG Therapeutics, Inc.
TGTX
$42.54
-$0.60-1.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 514.43M | 141.97M | 131.58M | 251.87M | 276.24M |
| Total Receivables | 392.05M | 305.63M | 265.38M | 231.52M | 190.12M |
| Inventory | 129.03M | 125.59M | 146.95M | 155.20M | 157.76M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 51.46M | 57.58M | 55.85M | 25.37M | 20.39M |
| Total Current Assets | 1.09B | 630.76M | 599.77M | 663.96M | 644.51M |
|
|
|||||
| Total Current Assets | 1.09B | 630.76M | 599.77M | 663.96M | 644.51M |
| Net Property, Plant & Equipment | 6.48M | 6.28M | 6.50M | 6.72M | 6.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 373.85M | 367.08M | 370.00M | 3.34M | 3.35M |
| Total Assets | 1.53B | 1.06B | 1.03B | 702.61M | 656.69M |
|
|
|||||
| Total Accounts Payable | 69.25M | 47.41M | 61.64M | 86.52M | 93.83M |
| Total Accrued Expenses | 39.26M | 41.05M | 15.01M | 10.61M | 5.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.82M | 1.73M | 1.89M | 1.90M | 1.99M |
| Total Finance Division Other Current Liabilities | 76.79M | 63.57M | 78.27M | 72.86M | 59.25M |
| Total Other Current Liabilities | 76.79M | 63.57M | 78.27M | 72.86M | 59.25M |
| Total Current Liabilities | 187.11M | 153.76M | 156.81M | 171.89M | 160.21M |
|
|
|||||
| Total Current Liabilities | 187.11M | 153.76M | 156.81M | 171.89M | 160.21M |
| Long-Term Debt | 745.14M | 245.65M | 245.34M | 245.04M | 244.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.60M | 7.02M | 7.31M | 7.59M | 7.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.86M | 8.81M | 8.35M | 1.67M | 6.60M |
| Total Liabilities | 945.71M | 415.23M | 417.81M | 426.18M | 419.40M |
|
|
|||||
| Common Stock & APIC | 1.85B | 1.83B | 1.81B | 1.79B | 1.78B |
| Retained Earnings | -1.06B | -1.08B | -1.11B | -1.50B | -1.52B |
| Treasury Stock & Other | -200.23M | -100.23M | -100.23M | -21.99M | -15.12M |
| Total Common Equity | 583.13M | 648.02M | 607.22M | 276.43M | 237.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 583.13M | 648.02M | 607.22M | 276.43M | 237.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 583.13M | 648.02M | 607.22M | 276.43M | 237.29M |
|
|
|||||